REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Miraxbiofarma AO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Miraxbiofarma AO Profile Updated: January 09, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

Miraxbiofarma AO is based in Russia. The head office is in Moscow. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on November 14, 2005. It currently has a total number of 77 (2022) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 3.37% in 2022. There was a total negative growth of 38.56% in Miraxbiofarma AO’s total assets over the same period.

Headquarters
Ulitsa Bryanskaya, Dom 5
Moscow; Moscow; Postal Code: 121059

Contact Details: Purchase the Miraxbiofarma AO report to view the information.

Website: http://mbfarma.ru

Basic Information
Total Employees:
Purchase the Miraxbiofarma AO report to view the information.
Outstanding Shares:
Purchase the Miraxbiofarma AO report to view the information.
Registered Capital:
Purchase the Miraxbiofarma AO report to view the information.
Incorporation Date:
November 14, 2005
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
45%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
5%
Subsidiaries
ANO Nacionalinyi Institut Innovacii
Company Performance
Financial values in the chart are available after Miraxbiofarma AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-3.37%▼
Total operating revenue
-3.37%▼
Operating profit (EBIT)
17.87%▲
Net Profit (Loss) for the Period
N/A
Total assets
-38.56%▼
Total equity
-34.25%▼
Operating Profit Margin (ROS)
0.59%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.75%▼
Cash Ratio
-0.36%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo